Conantokin R
Alternative Names: Con RLatest Information Update: 04 Dec 2003
At a glance
- Originator Cognetix
- Class
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Seizures
Most Recent Events
- 04 Dec 2003 No development reported - Preclinical for Seizures in USA (unspecified route)
- 23 Feb 2000 New profile
- 23 Feb 2000 Preclinical development for Seizures in USA (Unknown route)